| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma (NCT05464823) | M.D. Anderson Cancer Center | 2022-07-07 |
| Comparative Quantification of MTX and Its Metabolites Post Glucarpidase (NCT05250869) | Charite University, Berlin, Germany | 2022-07-06 |
| A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. (NCT05878691) | Glenmark Specialty S.A. | 2022-06-28 |
| SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes (NCT05754814) | Rigshospitalet, Denmark | 2022-06-28 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR) (NCT05371132) | City of Hope Medical Center | 2022-06-20 |
| A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma (NCT05390528) | Shanghai Henlius Biotech | 2022-06-20 |
| Endobronchial Ultrasound Needle Aspiration With and Without Suction (NCT05110950) | Università Politecnica delle Marche | 2022-06-01 |
| Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV (NCT07032103) | Samsung Medical Center | 2022-06-01 |
| Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis (NCT05388838) | Hospices Civils de Lyon | 2022-06-01 |
| Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies (NCT05275036) | Sun Yat-sen University | 2022-05-31 |
| A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma (NCT05389293) | Memorial Sloan Kettering Cancer Center | 2022-05-27 |
| Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients (NCT05396118) | Rigshospitalet, Denmark | 2022-05-18 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| A Retrospective Study on Extranodal DLBCL (NCT06549361) | Ruijin Hospital | 2022-05-01 |
| Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma (NCT05294055) | Institute of Hematology & Blood Diseases Hospital, China | 2022-04-26 |
| Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma (NCT06060080) | Yao Liu | 2022-04-22 |
| Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma (NCT05294367) | Mayo Clinic | 2022-04-15 |
| Early Integration of Palliative and Supportive Care in Cellular Therapy (NCT05190653) | Alberta Health Services, Calgary | 2022-04-08 |
| Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality (NCT05095155) | Asfendiyarov Kazakh National Medical University | 2022-04-01 |
| Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant (NCT05338047) | Hospital Universitario Dr. Jose E. Gonzalez | 2022-04-01 |
| A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma (NCT04980222) | Hoffmann-La Roche | 2022-03-22 |
| Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant (NCT05274763) | Emory University | 2022-03-21 |
| PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation (NCT05120570) | Masonic Cancer Center, University of Minnesota | 2022-03-17 |
| Long-Term Follow-up Study (NCT05332054) | Caribou Biosciences, Inc. | 2022-03-16 |
| Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy (NCT05064787) | Pack Health | 2022-03-11 |
| Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia (NCT04961801) | Shin Mineishi | 2022-03-01 |
| Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells (NCT06026995) | Chongqing University Cancer Hospital | 2022-03-01 |
| A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. (NCT05598268) | ImmVira Pharma Co. Ltd | 2022-03-01 |
| Phase 1 First-in-human Study of JS014 (NCT05296772) | Anwita Biosciences | 2022-02-28 |
| Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma (NCT05239676) | Zhejiang University | 2022-02-28 |
| UPLYFT For Lymphoma Survivors (NCT05080166) | Dana-Farber Cancer Institute | 2022-02-08 |
| Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH) (NCT06781437) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2022-02-01 |
| Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT (NCT05493800) | MitoImmune Therapeutics | 2022-02-01 |
| Feasibility, Acceptability, and Preliminary Effects of Lymfit (NCT05259657) | McGill University | 2022-02-01 |
| The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients (NCT05214144) | Yale University | 2022-01-27 |
| Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL (NCT05153330) | Biomea Fusion Inc. | 2022-01-24 |
| Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors (NCT05257785) | McGill University | 2022-01-15 |
| Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors (NCT05378256) | Centre Hospitalier Régional d'Orléans | 2022-01-10 |
| Danish Elder Lymphoma Patient Hematopoietic Investigation (NCT05245487) | Rigshospitalet, Denmark | 2022-01-01 |
| PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells (NCT05176275) | The First Affiliated Hospital of Soochow University | 2022-01-01 |
| Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma (NCT05155215) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2021-12-31 |
| A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT05055791) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-12-29 |
| Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors (NCT05156203) | Taivex Therapeutics Corporation | 2021-12-19 |
| A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects (NCT05049083) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-17 |
| A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma (NCT05081479) | Memorial Sloan Kettering Cancer Center | 2021-12-08 |
| Italian Study of Patients With Lymphoma (NCT06814925) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-12-07 |
| Quest to Analyze One Thousand Humans Meditating (NCT06583395) | Tobias Moeller-Bertram | 2021-12-05 |
| Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia (NCT04541212) | Montreal Heart Institute | 2021-12-02 |
| PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation (NCT05156554) | Sun Yat-sen University | 2021-12-01 |
| The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study (NCT04957901) | Sun Yat-sen University | 2021-12-01 |
| A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors (NCT05093322) | Hutchmed | 2021-11-30 |
| Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma (NCT05320081) | Huazhong University of Science and Technology | 2021-11-30 |
| SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations (NCT05393999) | Imperial College Healthcare NHS Trust | 2021-11-29 |
| Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant (NCT04898790) | University of Nebraska | 2021-11-18 |
| Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies (NCT05203809) | Malaghan Institute of Medical Research | 2021-11-18 |
| A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer (NCT04827810) | Fox Chase Cancer Center | 2021-11-05 |
| Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant (NCT04985409) | Cedars-Sinai Medical Center | 2021-10-26 |
| Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide (NCT06069024) | Qianfoshan Hospital | 2021-10-15 |
| Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma (NCT04931875) | RenJi Hospital | 2021-10-11 |
| A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma (NCT05078593) | Shanghai Henlius Biotech | 2021-10-11 |
| Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma (NCT05019976) | University of Chicago | 2021-09-30 |
| HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide (NCT04904588) | Center for International Blood and Marrow Transplant Research | 2021-09-30 |
| SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer (NCT04977024) | GeoVax, Inc. | 2021-09-27 |
| Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies (NCT05528887) | The Affiliated People's Hospital of Ningbo University | 2021-09-16 |
| Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT (NCT04764513) | Chinese PLA General Hospital | 2021-09-12 |
| A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma (NCT04970992) | Da Zen Theranostics Inc | 2021-08-12 |
| To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors (NCT06558513) | Evopoint Biosciences Inc. | 2021-08-03 |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma (NCT04983810) | Cyclacel Pharmaceuticals, Inc. | 2021-07-12 |
| Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma (NCT04739813) | National Cancer Institute (NCI) | 2021-07-09 |
| Removing Transfusion Dependence as a Barrier to Hospice Enrollment (NCT05063591) | Adam Olszewski | 2021-07-09 |
| A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies (NCT04556266) | Memorial Sloan Kettering Cancer Center | 2021-07-01 |
| DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase) (NCT04162431) | University of Exeter | 2021-06-28 |
| Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer (NCT04716153) | University Hospital, Montpellier | 2021-06-25 |
| ALPN-202 With PD-1 Inhibition in Advanced Malignancies (NCT04920383) | Alpine Immune Sciences, Inc. | 2021-06-22 |
| IIT2020-20-SHIRAZIP-WALK: Nature Walks (NCT04896580) | Cedars-Sinai Medical Center | 2021-06-21 |
| A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma (NCT04837222) | Takeda | 2021-06-07 |
| CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) (NCT04637763) | Caribou Biosciences, Inc. | 2021-05-26 |
| A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy (NCT04570423) | Spectrum Pharmaceuticals, Inc | 2021-05-20 |
| An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma (NCT04873440) | Chinese PLA General Hospital | 2021-05-06 |
| A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy (NCT04847050) | National Cancer Institute (NCI) | 2021-04-28 |
| Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma (NCT04818372) | Keymed Biosciences Co.Ltd | 2021-04-26 |
| Endobronchial Diagnosis of Lymphoma (NCT05075655) | University Hospital, Caen | 2021-04-20 |
| HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma (NCT04668768) | Fox Chase Cancer Center | 2021-04-16 |
| A Feasibility Study in Chronically Fatigued Cancer Survivors (NCT04931407) | Oslo University Hospital | 2021-04-06 |
| Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma (NCT04910594) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-04-01 |
| Predictors of Malnutrition in Patients With Haematological Cancer (NCT05209321) | Jens Rikardt Andersen | 2021-04-01 |
| Telerehabilitation and Lymphoma Patients (NCT04822389) | Brno University Hospital | 2021-04-01 |
| Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma (NCT04797182) | Sun Yat-sen University | 2021-04-01 |
| Pilot Study of an NTproBNP Guided Strategy of Cardioprotection (NCT04737265) | Abramson Cancer Center at Penn Medicine | 2021-03-18 |
| Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL (NCT02546739) | Beijing Doing Biomedical Co., Ltd. | 2021-03-01 |
| Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL (NCT03271515) | Beijing Doing Biomedical Co., Ltd. | 2021-03-01 |
| Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy (NCT04465760) | OHSU Knight Cancer Institute | 2021-02-25 |
| Patient Reported Outcomes and Patient Education in Cellular Therapy Patients (NCT04853277) | Dartmouth-Hitchcock Medical Center | 2021-02-07 |
| Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer (NCT04706676) | Rigshospitalet, Denmark | 2021-01-26 |
| A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT04657302) | Hoffmann-La Roche | 2021-01-08 |
| The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19 (NCT04746092) | Tel-Aviv Sourasky Medical Center | 2021-01-06 |
| Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children (NCT05179850) | West China Hospital | 2021-01-01 |
| Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma (NCT04460508) | The First Hospital of Jilin University | 2020-12-20 |